State Board of Administration of Florida Retirement System’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $461K | Hold |
14,537
| – | – | ﹤0.01% | 1556 |
|
|
2025
Q4 | $395K | Hold |
14,537
| – | – | ﹤0.01% | 1649 |
|
|
2025
Q3 | $376K | Hold |
14,537
| – | – | ﹤0.01% | 1662 |
|
|
2025
Q2 | $296K | Hold |
14,537
| – | – | ﹤0.01% | 1747 |
|
|
2025
Q1 | $264K | Hold |
14,537
| – | – | ﹤0.01% | 1765 |
|
|
2024
Q4 | $367K | Hold |
14,537
| – | – | ﹤0.01% | 1675 |
|
|
2024
Q3 | $494K | Hold |
14,537
| – | – | ﹤0.01% | 1562 |
|
|
2024
Q2 | $538K | Buy |
14,537
+4,940
| +51% | +$186K | ﹤0.01% | 1484 |
|
|
2024
Q1 | $345K | Sell |
9,597
-3,780
| -28% | -$155K | ﹤0.01% | 1703 |
|
|
2023
Q4 | $531K | Hold |
13,377
| – | – | ﹤0.01% | 1575 |
|
|
2023
Q3 | $368K | Buy |
13,377
+190
| +1% | +$5.96K | ﹤0.01% | 1721 |
|
|
2023
Q2 | $447K | Buy |
13,187
+3,590
| +37% | +$121K | ﹤0.01% | 1635 |
|
|
2023
Q1 | $345K | Hold |
9,597
| – | – | ﹤0.01% | 1769 |
|
|
2022
Q4 | $428K | Buy |
9,597
+560
| +6% | +$20K | ﹤0.01% | 1687 |
|
|
2022
Q3 | $254K | Hold |
9,037
| – | – | ﹤0.01% | 1952 |
|
|
2022
Q2 | $244K | Buy |
9,037
+70
| +0.8% | +$2.03K | ﹤0.01% | 2027 |
|
|
2022
Q1 | $305K | Hold |
8,967
| – | – | ﹤0.01% | 1995 |
|
|
2021
Q4 | $346K | Buy |
8,967
+3,204
| +56% | +$140K | ﹤0.01% | 1997 |
|
|
2021
Q3 | $311K | Buy |
+5,763
| New | +$270K | ﹤0.01% | 2083 |
|
|
2018
Q2 | – | Sell |
-4,870
| Closed | -$170K | – | 2404 |
|
|
2018
Q1 | $170K | Hold |
4,870
| – | – | ﹤0.01% | 2270 |
|
|
2017
Q4 | $207K | Hold |
4,870
| – | – | ﹤0.01% | 2239 |
|
|
2017
Q3 | $209K | Hold |
4,870
| – | – | ﹤0.01% | 2268 |
|
|
2017
Q2 | $180K | Hold |
4,870
| – | – | ﹤0.01% | 2307 |
|
|
2017
Q1 | $264K | Hold |
4,870
| – | – | ﹤0.01% | 2124 |
|
|
2016
Q4 | $259K | Hold |
4,870
| – | – | ﹤0.01% | 2152 |
|
|
2016
Q3 | $295K | Hold |
4,870
| – | – | ﹤0.01% | 2085 |
|
|
2016
Q2 | $321K | Hold |
4,870
| – | – | ﹤0.01% | 2006 |
|
|
2016
Q1 | $276K | Hold |
4,870
| – | – | ﹤0.01% | 2091 |
|
|
2015
Q4 | $1.15M | Buy |
4,870
+12
| +0.2% | +$2.62K | ﹤0.01% | 1388 |
|
|
2015
Q3 | $768K | Buy |
4,858
+11
| +0.2% | +$3.11K | ﹤0.01% | 1617 |
|
|
2015
Q2 | $1.83M | Buy |
4,847
+52
| +1% | +$20.7K | 0.01% | 1182 |
|
|
2015
Q1 | $2M | Sell |
4,795
-192
| -4% | -$68.7K | 0.01% | 1128 |
|
|
2014
Q4 | $1.36M | Buy |
4,987
+39
| +0.8% | +$9.7K | ﹤0.01% | 1380 |
|
|
2014
Q3 | $962K | Hold |
4,948
| – | – | ﹤0.01% | 1584 |
|
|
2014
Q2 | $1.21M | Buy |
4,948
+327
| +7% | +$73.8K | ﹤0.01% | 1497 |
|
|
2014
Q1 | $1.23M | Buy |
4,621
+35
| +0.8% | +$13.4K | ﹤0.01% | 1439 |
|
|
2013
Q4 | $1.67M | Sell |
4,586
-25
| -0.5% | -$9.63K | 0.01% | 1242 |
|
|
2013
Q3 | $2.45M | Hold |
4,611
| – | – | 0.01% | 1035 |
|
|
2013
Q2 | $1.08M | Buy |
+4,611
| New | +$908K | ﹤0.01% | 1481 |
|
Other funds holding CLDX
KCM
VCM
CC
EP
State Board of Administration of Florida Retirement System's CLDX Position: Q1 2026 in Review
State Board of Administration of Florida Retirement System held its Celldex Therapeutics (CLDX) position steady in Q1 2026 at 14,537 shares worth $461K. The position accounts for ﹤0.01% of the portfolio, ranked #1556.
State Board of Administration of Florida Retirement System first reported a position in CLDX in Q2 2013 and has held it in 39 quarters since. The position peaked at $2.45M in Q3 2013. 228 funds tracked by Wall St. Rank hold CLDX as of Q1 2026.
- State Board of Administration of Florida Retirement System held 14,537 shares of Celldex Therapeutics worth $461K as of Q1 2026.
- State Board of Administration of Florida Retirement System left its Celldex Therapeutics share count unchanged in Q1 2026.
- Celldex Therapeutics made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q1 2026, its #1556 holding.
- State Board of Administration of Florida Retirement System first reported a position in Celldex Therapeutics in Q2 2013 and has held it in 39 quarters since.
- State Board of Administration of Florida Retirement System's Celldex Therapeutics position peaked at $2.45M in Q3 2013.
- 228 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q1 2026.
Based on State Board of Administration of Florida Retirement System's 13F filing for Q1 2026, filed 8 May 2026.